Admera Health

Admera Health is designing advanced molecular diagnostics and pharmacogenomics (PGx) solutions to facilitate personalized medicine and non-invasive cancer testing. PGx involves understanding the relationship between a person's genetic makeup and their response to different drugs to develop effective and safe medications tailored to the individual. Admera has built their flagship product, PGxOne Plus, that incorporates next-generation gene sequencing design applications and expert data curation to offer a comprehensive test built to enable smarter and safer medication management. Admera’s portfolio of genetic tests also include OncoGxOne for solid tumor profiling and CardioGxOne for cardiovascular disease conditions.

Jobs: